Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes-Reference-Cited by-同舟云学术

Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes

Author:

Cheung A. C.¹,Lapointe-Shaw L.²,Kowgier M.¹³,Meza-Cardona J.⁴,Hirschfield G. M.⁵,Janssen H. L. A.¹,Feld J. J.¹⁶

Affiliation:

1. Toronto Centre for Liver Disease; Toronto Western and General Hospital; University Health Network; University of Toronto; Toronto Canada

2. Mount Sinai Hospital and Department of Medicine; University of Toronto; Toronto Canada

3. Dalla Lana School of Public Health; University of Toronto; Toronto Canada

4. Department of Gastroenterology and Hepatology; Hospital Español; Mexico D.F Mexico

5. Centre for Liver Research; National Institute for Health Research Biomedical Research Unit; University of Birmingham; Birmingham UK

6. McLaughlin-Rotman Centre for Global Health; University of Toronto; Toronto Canada

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

Reference36 articles.

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献